Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0J7RW
|
||||
Former ID |
DNC005282
|
||||
Drug Name |
WIN-55212-2
|
||||
Drug Type |
Small molecular drug
|
||||
Structure |
Download2D MOL |
||||
Formula |
C27H26N2O3
|
||||
InChI |
InChI=1S/C27H26N2O3/c1-18-25(27(30)22-9-4-7-19-6-2-3-8-21(19)22)23-10-5-11-24-26(23)29(18)20(17-32-24)16-28-12-14-31-15-13-28/h2-11,20H,12-17H2,1H3/t20-/m1/s1
|
||||
InChIKey |
HQVHOQAKMCMIIM-HXUWFJFHSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
7980892, 11056544, 12014569, 14782868, 14929727, 26754855, 26754856, 39341166, 47647616, 48395014, 49681172, 49689353, 50110805, 50110806, 57359506, 77916044, 85787707, 90341664, 92309954, 99300867, 103513296, 124750377, 124881896, 124881897, 124881898, 124881899, 124881900, 124881901, 124881902, 128100013, 134342487, 135651326, 142472540, 162169305, 164766158, 179335180, 223591298, 226490429, 249967380, 252319849
|
||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 1 | Target Info | Inhibitor | [530009] | |
Cannabinoid receptor 2 | Target Info | Inhibitor | [528907] | ||
PANTHER Pathway | Endogenous cannabinoid signaling | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
References | |||||
Ref 542353 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 733). | ||||
Ref 545702 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004262) | ||||
Ref 528907 | Eur J Med Chem. 2008 Mar;43(3):513-39. Epub 2007 May 6.Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor. | ||||
Ref 530009 | Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. Epub 2009 Feb 21.Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.